SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 342.80 |
| Enterprise Value ($M) | 529.70 |
| Book Value ($M) | 418.57 |
| Book Value / Share | 8.47 |
| Price / Book | 0.82 |
| NCAV ($M) | 67.14 |
| NCAV / Share | 1.36 |
| Price / NCAV | 5.11 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.24 |
| Return on Assets (ROA) | -0.16 |
| Return on Equity (ROE) | -0.29 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 5.32 |
| Current Ratio | 5.70 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 350.34 |
| Assets | 701.76 |
| Liabilities | 283.19 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Earnings Per Share Basic And Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G | Alger Associates Inc | 5.50 | 35.68 | |
| 13G/A | Brown Capital Management Llc | 10.43 | -23.73 | |
| 13G/A | Cadian Capital Management, Lp | 8.70 | 24.65 | |
| 13G/A | Vanguard Group Inc | 5.74 | 0.00 | |
| 13G/A | Integrated Core Strategies (us) Llc | 7.50 | 32.42 | |
| 13G | Morgan Stanley | 8.50 | ||
| 13G/A | BlackRock, Inc. | 7.30 | 13.50 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 47,712 | 511,885 | 9.32 | |
| 45,820 | 331,203 | 13.83 | |
| 82,197 | 502,213 | 16.37 | |
| 73,609 | 466,126 | 15.79 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| CVKD – Cadrenal Therapeutics, Inc. | CYCC – Cyclacel Pharmaceuticals, Inc. |
| CYCN – Cyclerion Therapeutics, Inc. | CYTH – Cyclo Therapeutics, Inc. |
| DARE – Daré Bioscience, Inc. |
Financial data and stock pages provided by
Fintel.io